Archive for March 2024
What to Expect from Senate Bill 410
Michigan has repealed the immunity provision of its Product Liability Act. This provision has been on the books for the last 30 years, allowing Michigan companies to shield themselves from liability for many cases, including opioid use. Senate Bill 410 went into effect on February 13, 2024, but without any retroactive effect. Injuries that…
Read MoreMASSIVE Increased Settlement by $110k with Medical Cost Projection
Recently, a worker’s compensation firm asked us to review one of their cases. Their plaintiff required a shoulder replacement. The defense initially offered $100,000 based almost entirely on past medical bills. Our nurse reviewed the documentation and created a Medical Cost Projection that accurately projected the cost for surgery, recovery, follow-up, and all related…
Read MoreFirm Profitability: Key Indicators to Track
By MASSIVE Partner, Todd Franklin Many attorneys tell me they want to run their law firm more efficiently, but don’t know how to get started. If lien resolution is a concern, my advice is to focus on both Leading and Lagging Indicators. Indicators from pre-settlement to post-settlement can teach you about your business and…
Read MoreLooking Ahead in 2024: Women in Mass Torts
By MASSIVE Partner, Marcy B. Spitz, Esq. The plaintiff-side of mass torts has admirably attempted to increase diversity. These improvements continue into 2024 with many mass tort cases expected to come to the forefront with more diverse leadership. Judges, law firm leadership, and the public are acutely aware of the need to have diverse…
Read MoreMedicare Lien Reduced by 99%
An Arkansas woman sustained injuries to her eye after using the Beovu eye injection from Novartis. The plaintiff ended up with a $75,388.62 Medicare lien. Patricia Stalnaker, Lead Lien Resolution Manager, and the Mass Tort team at MASSIVE reviewed the documentation and saw that a good portion of the treatments were for “age-related macular…
Read More